Diatech Diabetes, headquartered in Memphis, TN, is a medical device company revolutionizing the detection of infusion set failures in insulin pumps. The company addresses a critical need in diabetes management by providing a system that detects infusion set malfunctions, which current insulin pumps often fail to identify. This technology is crucial for insulin pump users, as undetected failures can lead to poor blood sugar control, hospitalizations, or even death.

Diatech Diabetes serves a global market of over 1 million insulin pump users, who collectively experience millions of infusion set failures annually. The company's primary clients are individuals using insulin pumps, healthcare providers, and potentially insurance companies looking to reduce the costs associated with diabetes-related complications.

The business model focuses on selling its infusion set failure detection system directly to consumers and through partnerships with healthcare providers and medical device manufacturers. Revenue is generated through the sale of the detection systems, as well as potential subscription services for continuous monitoring and updates.

By improving the reliability of insulin delivery, Diatech Diabetes aims to enhance the quality of life for diabetes patients and reduce the healthcare costs associated with infusion set failures.

Keywords: infusion set failure, insulin pump, diabetes management, medical device, patient safety, healthcare innovation, blood sugar control, detection system, Memphis TN, diabetes technology.